tiprankstipranks
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market

Atea Pharmaceuticals (AVIR) Income Statement

Compare
212 Followers

Atea Pharmaceuticals Income Statement

Last quarter (Q3 2024), Atea Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Atea Pharmaceuticals's net income was $-31.15M. See Atea Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 351.37M$ 48.63M$ 0.00
Gross Profit
$ -70.09M$ -260.00K$ 351.34M$ 48.61M$ -17.00K
Operating Expenses
$ 94.07M$ 130.65M$ 212.99M$ 59.66M$ 14.61M
Depreciation and Amortization
$ 416.00K$ 260.00K$ 29.00K$ 19.00K$ 17.00K
EBITDA
$ -119.59M$ -110.84M$ 138.41M$ -11.01M$ -14.59M
Operating Income
$ -164.16M$ -130.65M$ 138.38M$ -11.03M$ -14.61M
Other Income/Expenses
$ 29.22M$ 11.15M$ 213.00K$ 83.00K$ 574.00K
Pretax Income
$ -134.94M$ -119.50M$ 138.59M$ -10.95M$ -14.03M
Net Income
$ -135.96M$ -115.91M$ 121.19M$ -10.86M$ -13.46M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.63$ -1.39$ 1.46$ -0.13$ -0.16
Diluted EPS
$ -1.63$ -1.39$ 1.37$ -0.13$ -0.16
Weighted Average Shares Outstanding
83.39M 83.25M 82.82M 82.44M 82.62M
Weighted Average Shares Outstanding (Diluted)
83.39M 83.25M 88.25M 82.44M 82.62M
Currency in USD

Atea Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis